CBT and fluoxetine show comparable improvement for pediatric anxietyByBradley Peterson, MDAugust 26th 2026
FDA approves dolutegravir dispersible tablets for HIV-infected newbornsByMorgan Ebert, Executive EditorAugust 26th 2026
FDA authorizes first dual glucose-ketone monitor for children as young as 2ByMorgan Ebert, Executive EditorAugust 25th 2026
FDA approves nipocalimab as first treatment for warm autoimmune hemolytic anemiaByMorgan Ebert, Executive EditorAugust 25th 2026
New multisociety position paper details hospital strategies to close gaps in sepsis careByMorgan Ebert, Executive EditorAugust 25th 2026